Cargando…
“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”
The coronavirus 2019 (COVID-19) pandemic, as well as the resulting public health measures, impacted many aspects of society. The conduct of important pediatric vaccine trials was among these. Analyzing data from six ongoing non-COVID-19 pediatric vaccine trials we aimed to assess the operational imp...
Autores principales: | McArthur, Monica Anne, Bchir, Siham, Dubois, Estelle, Gan, Lucia, Gerchman, Eric, Gupta, Sandeep, Liabis, Olga, Perez, Lucia, Roche, Fabienne, Vasquez, Gustavo, Zambrano, Betzana, Gurunathan, Sanjay, Dhingra, Mandeep Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653681/ https://www.ncbi.nlm.nih.gov/pubmed/37942563 http://dx.doi.org/10.1080/21645515.2023.2272535 |
Ejemplares similares
-
Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
por: Madhi, Shabir A., et al.
Publicado: (2019) -
Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older
por: Neveu, David, et al.
Publicado: (2023) -
03. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered as a Booster Dose in Adults and Adolescents Vaccinated Against Meningococcal Disease 3 - 6 Years Earlier
por: Peterson, James, et al.
Publicado: (2021) -
04. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Meningococcal Vaccine-Naive Participants Across a Broad Age Range (2-55 Years) in Japan
por: Matsuoka, Osamu, et al.
Publicado: (2021) -
Economic Impact of Dengue Illness in the Americas
por: Shepard, Donald S., et al.
Publicado: (2011)